Shuying Chen1, Xuejian Xie1, Yujing Wang1, Yan Gao1, Xiaoli Xie1, Jing Yang1, Jixian Ye2. 1. Department of Cardiology, the 323th Hospital of PLA, Xi'an, Shaanxi, 710054, China. 2. Department of Cardiology, the 323th Hospital of PLA, Xi'an, Shaanxi, 710054, China. Electronic address: yejixian323@126.com.
Abstract
OBJECTIVE: Compelling epidemiological evidence indicates that alterations of mitochondrial DNA (mtDNA), including mutations and abnormal content of mtDNA, are associated with the initiation and development of cardiovascular disease. This study was undertaken to investigate whether mtDNA content in peripheral blood leukocytes (PBLs) could be used as a risk predictor for coronary heart disease (CHD). METHODS: The mtDNA content of PBLs from 378 CHD patients and 378 matched healthy controls was measured using quantitative real-time PCR-based method in a case-control study. An unconditional multivariate logistic regression model was applied to estimate the association between leukocyte mtDNA content and CHD risk. RESULTS: CHD patients exhibited notably lower mtDNA content than matched healthy controls (median, 0.65 vs. 0.86; P < 0.001). Compared with individuals who had high mtDNA content, individuals who had low mtDNA content had a significantly increased risk of CHD (adjusted OR, 2.38; 95% confidence interval, 1.33-4.69). A significant dose-response relation was observed between increased CHD risk and lower mtDNA content (Ptrend < 0.001). Furthermore, there was a significantly positive mtDNA content correlation between PBLs and atherosclerotic plaque tissue (ρ = 0.627, P = 0.039). In addition, a significant joint effect on the risk of CHD was noted between mtDNA content and cigarette smoking or plasma LDL-C concentration. CONCLUSIONS: This present study provide the first epidemiologic evidence linking low mtDNA content in PBLs to an increased CHD risk, which warrants further investigation in other populations.
OBJECTIVE: Compelling epidemiological evidence indicates that alterations of mitochondrial DNA (mtDNA), including mutations and abnormal content of mtDNA, are associated with the initiation and development of cardiovascular disease. This study was undertaken to investigate whether mtDNA content in peripheral blood leukocytes (PBLs) could be used as a risk predictor for coronary heart disease (CHD). METHODS: The mtDNA content of PBLs from 378 CHD patients and 378 matched healthy controls was measured using quantitative real-time PCR-based method in a case-control study. An unconditional multivariate logistic regression model was applied to estimate the association between leukocyte mtDNA content and CHD risk. RESULTS: CHD patients exhibited notably lower mtDNA content than matched healthy controls (median, 0.65 vs. 0.86; P < 0.001). Compared with individuals who had high mtDNA content, individuals who had low mtDNA content had a significantly increased risk of CHD (adjusted OR, 2.38; 95% confidence interval, 1.33-4.69). A significant dose-response relation was observed between increased CHD risk and lower mtDNA content (Ptrend < 0.001). Furthermore, there was a significantly positive mtDNA content correlation between PBLs and atherosclerotic plaque tissue (ρ = 0.627, P = 0.039). In addition, a significant joint effect on the risk of CHD was noted between mtDNA content and cigarette smoking or plasma LDL-C concentration. CONCLUSIONS: This present study provide the first epidemiologic evidence linking low mtDNA content in PBLs to an increased CHD risk, which warrants further investigation in other populations.
Authors: Foram N Ashar; Yiyi Zhang; Ryan J Longchamps; John Lane; Anna Moes; Megan L Grove; Josyf C Mychaleckyj; Kent D Taylor; Josef Coresh; Jerome I Rotter; Eric Boerwinkle; Nathan Pankratz; Eliseo Guallar; Dan E Arking Journal: JAMA Cardiol Date: 2017-11-01 Impact factor: 14.676
Authors: Shaowei Wu; Xin Li; Shasha Meng; Teresa Fung; Andrew T Chan; Geyu Liang; Edward Giovannucci; Immaculata De Vivo; Jin Hyup Lee; Hongmei Nan Journal: Am J Clin Nutr Date: 2019-02-01 Impact factor: 7.045
Authors: Christina A Castellani; Ryan J Longchamps; Jing Sun; Eliseo Guallar; Dan E Arking Journal: Mitochondrion Date: 2020-06-13 Impact factor: 4.160
Authors: Liron Ganel; Lei Chen; Ryan Christ; Jagadish Vangipurapu; Erica Young; Indraniel Das; Krishna Kanchi; David Larson; Allison Regier; Haley Abel; Chul Joo Kang; Alexandra Scott; Aki Havulinna; Charleston W K Chiang; Susan Service; Nelson Freimer; Aarno Palotie; Samuli Ripatti; Johanna Kuusisto; Michael Boehnke; Markku Laakso; Adam Locke; Nathan O Stitziel; Ira M Hall Journal: Hum Genomics Date: 2021-06-07 Impact factor: 6.481
Authors: Judita Knez; Ellen Winckelmans; Michelle Plusquin; Lutgarde Thijs; Nicholas Cauwenberghs; Yumei Gu; Jan A Staessen; Tim S Nawrot; Tatiana Kuznetsova Journal: Am J Epidemiol Date: 2015-12-24 Impact factor: 4.897